We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Novel Device Measures Glucose in Urine

By LabMedica International staff writers
Posted on 01 Dec 2015
Print article
Image: The GlucosAlarm device in the toilet can measure blood glucose levels through the urine and is activated through a smart phone application (Photo courtesy of Chihuahua Institute of Technology).
Image: The GlucosAlarm device in the toilet can measure blood glucose levels through the urine and is activated through a smart phone application (Photo courtesy of Chihuahua Institute of Technology).
A device has been developed that can measure glucose in blood through the urine in the toilet, and it activates via smart phone bluetooth, recording the values on a daily basis.

One of the values taken into account for the design was the pain caused by the use of needles for monitoring glucose in blood, which is partly responsible of why patients with diabetes do not keep proper control of their disease.

Two young technologists at the Chihuahua Institute of Technology (Mexico) developed the device which has achieved international recognition, included being one of the 10 most outstanding creations among innovators under 35 delivered by the MIT Tech Review; it also won the Global Innovation Competition for Science and Technology for the Benefit of Mankind (GIST Tech-I), an initiative promoted by the US President, where the team competed against 900 technological developments from all over the world.

The device is called the Glucosalarm (Brownsville, TX, USA) and it uses two 70 mL bottles, one contains an enzyme and the other one contains a cleaning solution, which last for 140 measurements and are easily replaceable. The device uses a light sensor that detects the frequency of glucose in urine and measures it in 15 to 40 seconds. Only one drop of urine is needed and this can be done when the patient uses the toilet and there is no need for painful blood testing. Another reason for not having a constant monitoring is the cost. A glucometer costs less than USD 30, but the test strips are expensive, as well as needles and needle holders, which is money that is not available to everyone. Glucosalarm will cost approximately USD 120 to USD 140 and the readings will cost less than a penny per measurement.

Currently, the device is in the third prototype and tests are performed with patients. It also has a patent in Mexico and the United States, and two medical device companies with international presence have shown interest in manufacturing it. Glucosalarm is expected to be released in the USA and Mexico in late 2016 and early 2017, once the necessary authorizations are obtained from the US Food and Drug Administration (FDA, Silver Springs, MD, USA) and the Mexican Federal Commission for the Protection against Sanitary Risk (COFEPRIS; Benito Juárez, Mexico).

Related Links:

Chihuahua Institute of Technology
GlucosAlarm 
US Food and Drug Administration 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.